Modulation of the immune system by Kaposi's sarcoma-associated herpesvirus.
about
A new insight into viral proteins as Immunomodulatory therapeutic agents: KSHV vOX2 a homolog of human CD200 as a potent anti-inflammatory proteinRecognition of human oncogenic viruses by host pattern-recognition receptorsKSHV: pathways to tumorigenesis and persistent infectionIdentification of Caspase-mediated Decay of Interferon Regulatory Factor-3, Exploited by a Kaposi Sarcoma-associated Herpesvirus Immunoregulatory ProteinKSHV reactivation and novel implications of protein isomerization on lytic switch controlThe RING-CH ligase K5 antagonizes restriction of KSHV and HIV-1 particle release by mediating ubiquitin-dependent endosomal degradation of tetherinKaposi sarcoma-associated herpesvirus latency-associated nuclear antigen inhibits interferon (IFN) beta expression by competing with IFN regulatory factor-3 for binding to IFNB promoterImmune escape of γ-herpesviruses from adaptive immunityConstruction and characterization of an infectious murine gammaherpesivrus-68 bacterial artificial chromosome.Kaposi Sarcoma Pathogenesis: A Triad of Viral Infection, Oncogenesis and Chronic Inflammation.The Kaposi's sarcoma-associated herpesvirus (KSHV)-induced 5-lipoxygenase-leukotriene B4 cascade plays key roles in KSHV latency, monocyte recruitment, and lipogenesis.Kaposi's sarcoma-associated herpesvirus-encoded latency-associated nuclear antigen reduces interleukin-8 expression in endothelial cells and impairs neutrophil chemotaxis by degrading nuclear p65.Looking at Kaposi's Sarcoma-Associated Herpesvirus-Host Interactions from a microRNA Viewpoint.Viral interferon regulatory factors are critical for delay of the host immune response against rhesus macaque rhadinovirus infection.Viral interferon regulatory factors decrease the induction of type I and type II interferon during rhesus macaque rhadinovirus infection.A Rhesus Rhadinovirus Viral Interferon (IFN) Regulatory Factor Is Virion Associated and Inhibits the Early IFN Antiviral Response.Epigenetic mechanisms in virus-induced tumorigenesis.Kaposi's sarcoma-associated herpesvirus inhibits expression and function of endothelial cell major histocompatibility complex class II via suppressor of cytokine signaling 3Kaposi's sarcoma and its associated herpesvirus.Professional antigen presenting cells in human herpesvirus 8 infection.Risk factors for seropositivity to Kaposi sarcoma-associated herpesvirus among children in UgandaNext-generation sequence analysis of the genome of RFHVMn, the macaque homolog of Kaposi's sarcoma (KS)-associated herpesvirus, from a KS-like tumor of a pig-tailed macaque.Implication of human herpesviruses in oncogenesis through immune evasion and supression.Viral microRNAs Target a Gene Network, Inhibit STAT Activation, and Suppress Interferon Responses.Role of virus-encoded microRNAs in herpesvirus biology.Viral epigenomes in human tumorigenesis.Prospects of a novel vaccination strategy for human gamma-herpesviruses.Missing links in antibody assembly control.HITS-CLIP and PAR-CLIP advance viral miRNA targetome analysis.Kaposi's sarcoma-associated herpesvirus-induced angiogenin plays roles in latency via the phospholipase C gamma pathway: blocking angiogenin inhibits latent gene expression and induces the lytic cycle.Marek's disease virus microRNA designated Mdv1-pre-miR-M4 targets both cellular and viral genes.Kaposi's sarcoma-associated herpesvirus and innate immunity.Construction and identification of recombinant lentiviral vector containing HIV-1 Tat gene and its expression in 293T cells.Identification of a lysosomal pathway regulating degradation of the bone morphogenetic protein receptor type II.Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor 3 inhibits gamma interferon and major histocompatibility complex class II expression.Suppression of antigen-specific T cell responses by the Kaposi's sarcoma-associated herpesvirus viral OX2 protein and its cellular orthologue, CD200.Reconstitution of immune responses against Kaposi sarcoma-associated herpesvirus.Small RNA profiling reveals antisense transcription throughout the KSHV genome and novel small RNAs.Caspase-dependent suppression of type I interferon signaling promotes KSHV lytic replication.The Kaposi's sarcoma-associated herpesvirus viral interleukin 6 gene affects metastasis and expression of B cell markers in a murine xenograft model
P2860
Q26751623-D8D1699D-F256-4758-A5F5-781EAAC36CA1Q27010116-9A3D6566-B526-4E3A-9850-6D54F2854D84Q27026000-95CE9FC8-2D94-4B24-98ED-DEAE2F624B30Q27489720-6F4969AD-BBD6-4053-B0B9-FE14868BD68FQ28080937-14ACAA3F-30C5-42EC-AD6C-D422E70BB2A7Q33564429-11CA5874-52AC-4A50-BABE-F9227F1439A0Q33748042-614980B8-FD29-4A96-A33D-33E542BC5628Q34345549-76DED500-3A9A-42BA-9A1B-D5E9F48760B2Q34427143-3A0FDD83-7466-4369-BBCF-0E0C7DB62750Q34644229-8B1047C7-3F88-4A02-946C-7802EB015A95Q35066362-57C35767-0A52-43EC-8289-ED887114CF39Q35192868-E016527E-ACA1-48CE-9086-3768BF93E648Q35671861-AB181B8D-F6A7-429F-BF1F-EF49D42E54C0Q35826066-19B90EA9-9ED4-4162-947A-2C1F2F855058Q35826613-DBAE0E6F-96AA-4E76-BB46-E62BEF2B9108Q35861143-BBBB6C47-1329-4671-8CAF-026C11C708F0Q36001887-C050290F-E8D3-491D-A72F-C2CD50978908Q36155542-8E9FA96A-B0B6-4E15-A86A-DFEED5104D3CQ36487309-B8AF1A48-5463-4C24-AEC1-B8027AD30AF3Q36546999-C7A029B1-4B1D-4D97-BCF7-09C68417FD10Q37000339-01E80E52-7377-40E2-9B38-60E3CEC6AACAQ37336869-3B50FE5F-AD9F-4FB3-AC88-7A893584A58EQ37522705-F04DF372-8E0A-419B-8254-08E67E21D17FQ37593352-35D8F4FB-8B53-48DD-8FB0-7702BAD59CC5Q37614650-46DF28AE-CB39-4544-906D-21ECBFE28295Q37681282-BCF789E5-3B46-4E70-B316-3F0B63BA3ADFQ37780705-F40300E9-66B7-44ED-A3E4-35A39522859EQ38184538-077ACC6B-B3AE-4B38-B5C4-100B1FBAC2BDQ38221158-30B00365-2B2B-4357-86D5-A48BB60C36F2Q39611761-39D723A4-0689-4FFC-B744-61BB7E721E3BQ39672411-43F7C1CB-BED3-4B7F-8EBF-8E0E9D8B560EQ39880184-B2273699-0C71-4D8E-B59D-E370EC8F632BQ41170298-9BB31D8E-4DB1-45F0-8AF7-41C8CA0F6AF4Q41713745-BD06178B-52B3-42C6-9B46-68D805786C71Q42059350-1DC7F47F-4A54-4C83-A45E-493211534894Q42196341-36C505D5-5B38-4CE6-81C1-E18CBBB613DEQ42446461-54E31619-4545-48E1-9691-F13A566518AFQ42727360-4989B216-4E5E-4058-8ED9-04660038B4F8Q50420476-6E795BAC-A1F7-4177-9798-4225DFD5B4F0Q59126441-97E6D6FE-C1E4-414C-82C1-29D9CD1D0B76
P2860
Modulation of the immune system by Kaposi's sarcoma-associated herpesvirus.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 18 February 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Modulation of the immune system by Kaposi's sarcoma-associated herpesvirus.
@en
Modulation of the immune system by Kaposi's sarcoma-associated herpesvirus.
@nl
type
label
Modulation of the immune system by Kaposi's sarcoma-associated herpesvirus.
@en
Modulation of the immune system by Kaposi's sarcoma-associated herpesvirus.
@nl
prefLabel
Modulation of the immune system by Kaposi's sarcoma-associated herpesvirus.
@en
Modulation of the immune system by Kaposi's sarcoma-associated herpesvirus.
@nl
P1476
Modulation of the immune system by Kaposi's sarcoma-associated herpesvirus
@en
P2093
Cristina Aresté
P304
P356
10.1016/J.TIM.2008.12.001
P577
2009-02-18T00:00:00Z